Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry		 vs
history
Cash-to-Debt 0.01
HCP's Cash-to-Debt is ranked lower than
86% of the 598 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 0.06 vs. HCP: 0.01 )
Ranked among companies with meaningful Cash-to-Debt only.
HCP' s Cash-to-Debt Range Over the Past 10 Years
Min: 0  Med: 0.01 Max: 0.52
Current: 0.01
0
0.52
Equity-to-Asset 0.38
HCP's Equity-to-Asset is ranked lower than
77% of the 642 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 0.52 vs. HCP: 0.38 )
Ranked among companies with meaningful Equity-to-Asset only.
HCP' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.31  Med: 0.47 Max: 0.6
Current: 0.38
0.31
0.6
Debt-to-Equity 1.45
HCP's Debt-to-Equity is ranked lower than
82% of the 613 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 0.81 vs. HCP: 1.45 )
Ranked among companies with meaningful Debt-to-Equity only.
HCP' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.08  Med: 1.01 Max: 2.75
Current: 1.45
0.08
2.75
Debt-to-EBITDA 8.21
HCP's Debt-to-EBITDA is ranked lower than
71% of the 608 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 5.75 vs. HCP: 8.21 )
Ranked among companies with meaningful Debt-to-EBITDA only.
HCP' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 4.76  Med: 6.38 Max: 9.88
Current: 8.21
4.76
9.88
Interest Coverage 1.39
HCP's Interest Coverage is ranked lower than
86% of the 614 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 3.35 vs. HCP: 1.39 )
Ranked among companies with meaningful Interest Coverage only.
HCP' s Interest Coverage Range Over the Past 10 Years
Min: 1.1  Med: 1.3 Max: 1.9
Current: 1.39
1.1
1.9
Piotroski F-Score: 5
Altman Z-Score: 0.86
Beneish M-Score: -3.59
WACC vs ROIC
5.07%
3.16%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry		 vs
history
Operating Margin % 22.85
HCP's Operating Margin % is ranked lower than
79% of the 618 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 50.42 vs. HCP: 22.85 )
Ranked among companies with meaningful Operating Margin % only.
HCP' s Operating Margin % Range Over the Past 10 Years
Min: 25.33  Med: 40.81 Max: 49.69
Current: 22.85
25.33
49.69
Net Margin % 3.61
HCP's Net Margin % is ranked lower than
87% of the 649 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 43.99 vs. HCP: 3.61 )
Ranked among companies with meaningful Net Margin % only.
HCP' s Net Margin % Range Over the Past 10 Years
Min: -31.64  Med: 35.41 Max: 70.51
Current: 3.61
-31.64
70.51
ROE % 1.16
HCP's ROE % is ranked lower than
86% of the 651 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 7.39 vs. HCP: 1.16 )
Ranked among companies with meaningful ROE % only.
HCP' s ROE % Range Over the Past 10 Years
Min: -5.58  Med: 7.96 Max: 9.14
Current: 1.16
-5.58
9.14
ROA % 0.46
HCP's ROA % is ranked lower than
87% of the 656 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 3.68 vs. HCP: 0.46 )
Ranked among companies with meaningful ROA % only.
HCP' s ROA % Range Over the Past 10 Years
Min: -2.61  Med: 3.44 Max: 4.86
Current: 0.46
-2.61
4.86
ROC (Joel Greenblatt) % 216.20
HCP's ROC (Joel Greenblatt) % is ranked higher than
53% of the 537 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 123.80 vs. HCP: 216.20 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
HCP' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 4.62  Med: 24.05 Max: 1071.67
Current: 216.2
4.62
1071.67
3-Year Revenue Growth Rate 4.30
HCP's 3-Year Revenue Growth Rate is ranked higher than
62% of the 560 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 2.20 vs. HCP: 4.30 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
HCP' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -16.5  Med: 4.3 Max: 24.2
Current: 4.3
-16.5
24.2
3-Year EBITDA Growth Rate 1.50
HCP's 3-Year EBITDA Growth Rate is ranked lower than
56% of the 504 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 2.90 vs. HCP: 1.50 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
HCP' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -21.2  Med: 1.5 Max: 30.4
Current: 1.5
-21.2
30.4
3-Year EPS without NRI Growth Rate 16.30
HCP's 3-Year EPS without NRI Growth Rate is ranked higher than
67% of the 475 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 5.60 vs. HCP: 16.30 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
HCP' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -45  Med: 5.4 Max: 98.5
Current: 16.3
-45
98.5
GuruFocus has detected 5 Warning Signs with HCP Inc HCP.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» HCP's 30-Y Financials

Financials (Next Earnings Date: 2018-11-01 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income
» HCP's Warning Signs

Warning Signs

Subscribe to see Warning Signs. .

Start your free trial

» Details

Guru Trades
Q3 2017

HCP Guru Trades in Q3 2017

George Soros 8,400 sh (New)
Steven Cohen 450,086 sh (New)
Ray Dalio 117,340 sh (New)
Barrow, Hanley, Mewhinney & Strauss 3,451,567 sh (+44.84%)
Ronald Muhlenkamp 18,000 sh (unchged)
Jim Simons Sold Out
Caxton Associates Sold Out
Paul Tudor Jones 52,623 sh (-19.97%)
Manning & Napier Advisors, Inc 154,695 sh (-33.43%)
» More
Q4 2017

HCP Guru Trades in Q4 2017

Pioneer Investments 474,479 sh (New)
Jim Simons 1,529,900 sh (New)
Steven Cohen 512,000 sh (+13.76%)
Ronald Muhlenkamp 18,000 sh (unchged)
Ray Dalio Sold Out
George Soros Sold Out
Paul Tudor Jones Sold Out
Barrow, Hanley, Mewhinney & Strauss 3,354,304 sh (-2.82%)
» More
Q1 2018

HCP Guru Trades in Q1 2018

Pioneer Investments 683,775 sh (+44.11%)
Barrow, Hanley, Mewhinney & Strauss 3,332,311 sh (-0.66%)
Steven Cohen 452,600 sh (-11.60%)
Jim Simons 134,800 sh (-91.19%)
» More
Q2 2018

HCP Guru Trades in Q2 2018

Paul Tudor Jones 47,634 sh (New)
Chris Davis 340,000 sh (New)
Richard Pzena 29,591 sh (New)
Barrow, Hanley, Mewhinney & Strauss 6,847,550 sh (+105.49%)
Steven Cohen 504,200 sh (+11.40%)
Pioneer Investments 655,806 sh (-4.09%)
» More
» Details

Insider Trades

Financial Reports

Latest Guru Trades with HCP

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Barrow, Hanley, Mewhinney & Strauss 2018-06-30 Add 105.49%0.14%$21.88 - $25.82 $ 26.5112%6,847,550
Chris Davis 2018-06-30 New Buy0.04%$21.88 - $25.82 $ 26.5112%340,000
Richard Pzena 2018-06-30 New Buy$21.88 - $25.82 $ 26.5112%29,591
Barrow, Hanley, Mewhinney & Strauss 2018-03-31 Reduce -0.66%$21.64 - $25.91 $ 26.5114%3,332,311
Barrow, Hanley, Mewhinney & Strauss 2017-12-31 Reduce -2.82%$25.21 - $27.23 $ 26.510%3,354,304
George Soros 2017-12-31 Sold Out 0.01%$25.21 - $27.23 $ 26.510%0
Barrow, Hanley, Mewhinney & Strauss 2017-09-30 Add 44.84%0.04%$27.66 - $32.55 $ 26.51-12%3,451,567
George Soros 2017-09-30 New Buy0.01%$27.66 - $32.55 $ 26.51-12%8,400
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: REITs » REIT - Healthcare Facilities    NAICS: 531390    SIC: 6798
Compare:NYSE:OHI, NYSE:HTA, NYSE:MPW, NAS:SNH, NYSE:VTR, NYSE:HR, NAS:SBRA, NYSE:NHI, NYSE:GEO, NYSE:DOC, NYSE:WELL, NYSE:QCP, LSE:AGR, NYSE:LTC, SGX:C2PU, NAS:CTRE, TSX:NWH.UN, NYSE:UHT, SGX:AW9U, NZSE:VHP » details
Traded in other countries:HC5.Germany,
Headquarter Location:USA
HCP Inc is a real estate investment trust. It invests in real estate serving the healthcare industry in the U.S. It acquires, develops, leases, manages and disposes of healthcare real estate and provides financing to healthcare providers.

HCP has interests in roughly 300 senior housing facilities, 100 life science properties, 200 medical office buildings, hospitals, and other healthcare properties. It also owns roughly $875 million of debt investments in these areas.

Top Ranked Articles about HCP Inc

Chris Davis’ Top 3 Buys in 2nd Quarter Top buys include Einhorn’s Greenlight Capital Re
August 13, 2018
Chris Davis (Trades, Portfolio), portfolio manager of the Davis Financial Fund, disclosed on Monday three new positions for the second quarter: Greenlight Capital Re Ltd. (NASDAQ:GLRE), HCP Inc. (NYSE:HCP) and Switch Inc. (NYSE:SWCH). Read more...
HCP Appoints Katherine Sandstrom to its Board of Directors
August 2, 2018
Read more...
Investor Expectations to Drive Momentum within NetApp, eBay, The Boeing, HCP, Atossa Genetics, and Anavex Life Sciences — Discovering Underlying Factors of Influence
July 30, 2018
Read more...
HCP Declares Quarterly Cash Dividend on Common Stock
July 26, 2018
Read more...
HCP to Report Second Quarter 2018 Financial Results and Host Conference Call/Webcast
July 5, 2018
Read more...
HCP Appoints Lydia Kennard and Kent Griffin to its Board of Directors
May 2, 2018
Read more...
HCP Declares Quarterly Cash Dividend on Common Stock
April 26, 2018
Read more...
HCP to Report First Quarter 2018 Financial Results and Host Conference Call/Webcast
April 5, 2018
Read more...
Wall Street Is in the Red on Thursday Retrailer skyrockets on earnings and revenue beat
March 22, 2018
U.S. markets are set to open low on Thursday, ahead of President Donald Trump idea of trade duties on China imports, which triggers fears about a potential trade war. Yesterday, the Fed raised interest rates to keep inflation under control. The rates are now in the range of 1.5% and 1.75%. It is expected that the economy will grow between 2.5% and 2.7%. Read more...
HCP Closes on the Sale of Its Tandem Mezzanine Loan Investment
March 15, 2018
Read more...

Ratios

vs
industry		 vs
history
PE Ratio 220.91
HCP's PE Ratio is ranked lower than
99% of the 586 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 15.50 vs. HCP: 220.91 )
Ranked among companies with meaningful PE Ratio only.
HCP' s PE Ratio Range Over the Past 10 Years
Min: 6.73  Med: 22.74 Max: 220.91
Current: 220.91
6.73
220.91
Forward PE Ratio 48.78
HCP's Forward PE Ratio is ranked lower than
88% of the 250 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 19.65 vs. HCP: 48.78 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 220.91
HCP's PE Ratio without NRI is ranked lower than
99% of the 581 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 15.60 vs. HCP: 220.91 )
Ranked among companies with meaningful PE Ratio without NRI only.
HCP' s PE Ratio without NRI Range Over the Past 10 Years
Min: 16.47  Med: 29.99 Max: 220.91
Current: 220.91
16.47
220.91
Price-to-Owner-Earnings 22.67
HCP's Price-to-Owner-Earnings is ranked lower than
68% of the 328 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 14.08 vs. HCP: 22.67 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
HCP' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 7.06  Med: 18.18 Max: 47.07
Current: 22.67
7.06
47.07
PB Ratio 2.42
HCP's PB Ratio is ranked lower than
89% of the 640 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 1.10 vs. HCP: 2.42 )
Ranked among companies with meaningful PB Ratio only.
HCP' s PB Ratio Range Over the Past 10 Years
Min: 0.76  Med: 1.63 Max: 2.75
Current: 2.42
0.76
2.75
PS Ratio 7.04
HCP's PS Ratio is ranked higher than
56% of the 614 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 7.55 vs. HCP: 7.04 )
Ranked among companies with meaningful PS Ratio only.
HCP' s PS Ratio Range Over the Past 10 Years
Min: 3.03  Med: 8.17 Max: 22.8
Current: 7.04
3.03
22.8
Price-to-Free-Cash-Flow 16.76
HCP's Price-to-Free-Cash-Flow is ranked higher than
57% of the 366 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 18.09 vs. HCP: 16.76 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
HCP' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 9.65  Med: 16.42 Max: 40.12
Current: 16.76
9.65
40.12
Price-to-Operating-Cash-Flow 14.54
HCP's Price-to-Operating-Cash-Flow is ranked higher than
53% of the 560 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 14.62 vs. HCP: 14.54 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
HCP' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 5.85  Med: 14.26 Max: 22.78
Current: 14.54
5.85
22.78
EV-to-EBIT 56.77
HCP's EV-to-EBIT is ranked lower than
93% of the 589 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 19.79 vs. HCP: 56.77 )
Ranked among companies with meaningful EV-to-EBIT only.
HCP' s EV-to-EBIT Range Over the Past 10 Years
Min: 17.3  Med: 25.2 Max: 249.6
Current: 56.77
17.3
249.6
EV-to-EBITDA 22.13
HCP's EV-to-EBITDA is ranked lower than
76% of the 601 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 15.96 vs. HCP: 22.13 )
Ranked among companies with meaningful EV-to-EBITDA only.
HCP' s EV-to-EBITDA Range Over the Past 10 Years
Min: 11.3  Med: 17 Max: 46.5
Current: 22.13
11.3
46.5
EV-to-Revenue 11.37
HCP's EV-to-Revenue is ranked higher than
62% of the 650 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 12.62 vs. HCP: 11.37 )
Ranked among companies with meaningful EV-to-Revenue only.
HCP' s EV-to-Revenue Range Over the Past 10 Years
Min: 8.5  Med: 14.8 Max: 33.5
Current: 11.37
8.5
33.5
Shiller PE Ratio 22.93
HCP's Shiller PE Ratio is ranked higher than
53% of the 233 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 23.55 vs. HCP: 22.93 )
Ranked among companies with meaningful Shiller PE Ratio only.
HCP' s Shiller PE Ratio Range Over the Past 10 Years
Min: 9.14  Med: 20.54 Max: 28.88
Current: 22.93
9.14
28.88
Current Ratio 3.26
HCP's Current Ratio is ranked higher than
84% of the 611 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 1.11 vs. HCP: 3.26 )
Ranked among companies with meaningful Current Ratio only.
HCP' s Current Ratio Range Over the Past 10 Years
Min: 0.3  Med: 3.07 Max: 16.77
Current: 3.26
0.3
16.77
Quick Ratio 3.26
HCP's Quick Ratio is ranked higher than
84% of the 611 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 1.01 vs. HCP: 3.26 )
Ranked among companies with meaningful Quick Ratio only.
HCP' s Quick Ratio Range Over the Past 10 Years
Min: 0.3  Med: 3.07 Max: 16.77
Current: 3.26
0.3
16.77
Days Sales Outstanding 9.08
HCP's Days Sales Outstanding is ranked higher than
69% of the 529 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 19.52 vs. HCP: 9.08 )
Ranked among companies with meaningful Days Sales Outstanding only.
HCP' s Days Sales Outstanding Range Over the Past 10 Years
Min: 8.31  Med: 49.89 Max: 105.09
Current: 9.08
8.31
105.09

Dividend & Buy Back

vs
industry		 vs
history
Dividend Yield % 5.58
HCP's Dividend Yield % is ranked higher than
58% of the 978 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 5.30 vs. HCP: 5.58 )
Ranked among companies with meaningful Dividend Yield % only.
HCP' s Dividend Yield % Range Over the Past 10 Years
Min: 4.12  Med: 5.95 Max: 12.57
Current: 5.58
4.12
12.57
Dividend Payout Ratio 10.57
HCP's Dividend Payout Ratio is ranked lower than
98% of the 700 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 1.03 vs. HCP: 10.57 )
Ranked among companies with meaningful Dividend Payout Ratio only.
HCP' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 1.07  Med: 2.19 Max: 10.57
Current: 10.57
1.07
10.57
3-Year Dividend Growth Rate -12.10
HCP's 3-Year Dividend Growth Rate is ranked lower than
87% of the 436 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 4.40 vs. HCP: -12.10 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
HCP' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: -12.1  Med: 4.2 Max: 7.6
Current: -12.1
-12.1
7.6
Forward Dividend Yield % 5.63
HCP's Forward Dividend Yield % is ranked lower than
52% of the 977 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 5.84 vs. HCP: 5.63 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 4.56
HCP's 5-Year Yield-on-Cost % is ranked lower than
75% of the 976 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 6.09 vs. HCP: 4.56 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
HCP' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 3.34  Med: 4.83 Max: 10.2
Current: 4.56
3.34
10.2
3-Year Average Share Buyback Ratio -0.70
HCP's 3-Year Average Share Buyback Ratio is ranked higher than
78% of the 507 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: -4.90 vs. HCP: -0.70 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
HCP' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -22.9  Med: -7.2 Max: -0.7
Current: -0.7
-22.9
-0.7

Valuation & Return

vs
industry		 vs
history
Price-to-Tangible-Book 2.57
HCP's Price-to-Tangible-Book is ranked lower than
90% of the 630 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 1.12 vs. HCP: 2.57 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
HCP' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.94  Med: 2.02 Max: 3.62
Current: 2.57
0.94
3.62
Price-to-Intrinsic-Value-Projected-FCF 0.87
HCP's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
65% of the 298 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 1.09 vs. HCP: 0.87 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
HCP' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.74  Med: 1.5 Max: 14.16
Current: 0.87
0.74
14.16
Price-to-Median-PS-Value 0.86
HCP's Price-to-Median-PS-Value is ranked higher than
80% of the 500 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 1.04 vs. HCP: 0.86 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
HCP' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.41  Med: 0.91 Max: 2.66
Current: 0.86
0.41
2.66
Price-to-Graham-Number 5.02
HCP's Price-to-Graham-Number is ranked lower than
98% of the 515 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 0.88 vs. HCP: 5.02 )
Ranked among companies with meaningful Price-to-Graham-Number only.
HCP' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.72  Med: 1.39 Max: 5.02
Current: 5.02
0.72
5.02
Earnings Yield (Greenblatt) % 1.76
HCP's Earnings Yield (Greenblatt) % is ranked lower than
87% of the 629 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 4.84 vs. HCP: 1.76 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
HCP' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 0.4  Med: 4 Max: 5.8
Current: 1.76
0.4
5.8
Forward Rate of Return (Yacktman) % 1.80
HCP's Forward Rate of Return (Yacktman) % is ranked lower than
57% of the 387 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 4.17 vs. HCP: 1.80 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
HCP' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -4.1  Med: 3.7 Max: 13.3
Current: 1.8
-4.1
13.3

More Statistics

Revenue (TTM) (Mil) $1,767.48
EPS (TTM) $ 0.12
Beta0.54
Volatility20.49%
52-Week Range $21.48 - 30.59
Shares Outstanding (Mil)469.83

Analyst Estimate

Dec18 Dec19 Dec20
Revenue (Mil $) 1,373 1,341 1,079
EBIT (Mil $) 480 474 456
EBITDA (Mil $) 1,006 996 998
EPS ($) 0.62 0.61 0.58
EPS without NRI ($) 0.62 0.61 0.58
EPS Growth Rate
(Future 3Y To 5Y Estimate)		 3.62%
Dividends per Share ($) 1.48 1.49 1.51

Piotroski F-Score Details

Piotroski F-Score: 55
Positive ROAY
Positive CFROAY
Higher ROA yoyN
CFROA > ROAY
Lower Leverage yoyN
Higher Current Ratio yoyY
Less Shares Outstanding yoyN
Higher Gross Margin yoyN
Higher Asset Turnover yoyY

» More Articles for HCP

Headlines

Articles On GuruFocus.com
Chris Davis’ Top 3 Buys in 2nd Quarter Aug 13 2018 
HCP Appoints Katherine Sandstrom to its Board of Directors Aug 02 2018 
Investor Expectations to Drive Momentum within NetApp, eBay, The Boeing, HCP, Atossa Genetics, and A Jul 30 2018 
HCP Declares Quarterly Cash Dividend on Common Stock Jul 26 2018 
HCP to Report Second Quarter 2018 Financial Results and Host Conference Call/Webcast Jul 05 2018 
HCP Appoints Lydia Kennard and Kent Griffin to its Board of Directors May 02 2018 
HCP Declares Quarterly Cash Dividend on Common Stock Apr 26 2018 
HCP to Report First Quarter 2018 Financial Results and Host Conference Call/Webcast Apr 05 2018 
Wall Street Is in the Red on Thursday Mar 22 2018 
HCP Closes on the Sale of Its Tandem Mezzanine Loan Investment Mar 15 2018 

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}